Introduction: Vitamin D deficiency (VDD) has been identified as a risk factor for diabetes mellitus and autoimmune diseases. Positive correlations between VDD and thyroid dysfunction among type 2 diabetes mellitus (T2DM) patients have been reported by several authors Therefore, in the present study, we examined the relationship between thyroid stimulating hormone (TSH) and vitamin D status among patients with T2DM. Results: A total of 2019 participants were included in this study. Average age of the study population was 51.3±16.4years. Expectedly, 47.5% had VDD. In 123 (6.1%) of the cases, TSH was lower than 0.22 mIU/L and in 1538 (74.0%), TSH was within normal reference range. Abnormally high levels of TSH (>4.2 mIU/L) were reported in 401 (19.9%) subjects. Serum 25-OHD level was significantly different among the study subgroups (P <0.0001). In post hoc analysis, it was determined that subjects with TSH levels <0.22 mIU/L had significantly higher 25-OHD concentrations (69.2±37.8 nmol/L) compared to subjects with normal TSH levels (58.0±31.3 nmol/L; P <0.0001) and those with elevated TSH concentrations (55.3±31.3 nmol/L; P <0.0001). However the difference in serum 25-OHD concentrations was not significant between subject with normal and those with elevated TSH levels (P=0.3).
Introduction
Vitamin D is an important element for skeletal health and it may also affect extra-skeletal health such as association with autoimmune diseases. [1] [2] [3] [4] [5] Inclusive studies in have reported an association between thyroid autoimmunity and 25-hydroxyvitamin D (25-OHD).
6-8 Type 2 diabetes mellitus (T2DM) prevalence in Saudi Arabia is high, reaching up to 30%. 9 Vitamin D deficiency (VDD) remains a major health problem. 10 VDD has received special attention lately because of its high incidence and its implication in the genesis of multiple chronic illnesses. The high prevalence of VDD in general population underlines the fact that VDD is more common in chronic diseases like diabetes mellitus.
T2DM and hypothyroidism are the main threats in developed and developing countries. 11, 12 T2DM increases the risk of thyroid dysfunction in the long-term. [13] [14] [15] [16] [17] [18] [19] T2DM and hypothyroidism are the primary reasons for mortality and morbidity in most high income and developing countries. [15] [16] [17] [18] [19] However, several studies have shown a higher prevalence of hypothyroidism occurring among T2DM patients. [17] [18] [19] [20] [21] [22] Moreover, positive correlations between VDD and hypothyroidism among T2DM patients have been reported. 1, 7, [21] [22] [23] 25-OHD was shown to affect the thyroid gland through immunemediated processes by directly inhibiting thyrotropin-stimulated iodide uptake. 24 Moreover, high 25-OHD status is associated with low thyroid-stimulating hormone (TSH). 25 Therefore, in the present study, we examined the relationship between serum TSH levels and vitamin D status among patients with T2DM. 1 Glycosylated hemoglobin (HbA1c) was measured by the high performance liquid chromatography method (Bio-Rad Laboratories, Waters, MA, USA). TSH levels between 0.22-4.2 mIU/L were regarded normal. 26 Participants were divided to three subgroups according to their TSH level (below <0.22 mIU/L, 0.22-4.2 mIU/L and >4.2 mIU/L). 27 The study was approved by the ethical committee board of King Fahad Armed Forces Hospital.
Methods

Statistical analysis
Data are presented as means±standard deviation (SD) or numbers (%). Quantitative variables were compared between two groups by using the Student's test. Differences in categorical variables were analysed using the chi-square test. Differences in mean serum 25-OHD levels were tested with ANOVA. The relationship between continuous variables was assessed using coefficients of correlation. Linear regression analyses were performed to examine the factors that predicted serum concentrations of 25(OH)D. Multivariate linear regression model was constructed using serum 25(OH)D and serum TSH as the dependent variables and factors with either a P-value less than 0.15 in the univariate analysis or a previously reported association with either 25-OHD or TSH as independent variables. Logistic regression analysis was carried out to estimate odds ratio (OR) and 95% CI. P value <0.05 indicates significance. The statistical analysis was conducted with SPSS version 23.0 for Windows.
Results
A total of 2019 participants were included in this study. Average age of the study population was 51.3±16.4years (Table 1) . Expectedly, 47.5% had VDD. In 123 (6.1%) of the cases, TSH was lower than 0.22 mIU/L and in 1538 (74.0%), TSH was within normal reference range. Abnormally high levels of TSH (>4.2 mIU/L) were reported in 401 (19.9%) subjects. Table 1 summarizes the characteristics of the three subgroups of study population according to their serum TSH level. Serum 25-OHD level was significantly different among the study subgroups (P <0.0001). In post hoc analysis, it was determined that subjects with TSH levels <0.22 mIU/L had significantly higher 25-OHD concentrations (69.2±37.8 nmol/L) compared to subjects with normal TSH levels (58.0±31.3 nmol/L; P <0.0001) and those with elevated TSH concentrations (55.3±31.3 nmol/L; P <0.0001). However the difference in serum 25-OHD concentrations was not significant between subject with normal and those with elevated TSH levels (P = 0.3). In order to identify the independent factors affecting 25-OHD levels, a multivariate linear regression model was constructed using the serum 25-OHD concentrations as the dependent factor (Table 2) . Age, gender, HbA1c and TSH were the independent predictors of 25-OHD levels. The second linear regression analysis using serum TSH concentrations as the dependent variable was performed with Age, gender, HbA1c and 25-OHD levels as independent variables. In the constructed model, age, gender and HbA1c and 25-OHD were found not to be independent predictors of serum TSH level (Table 3 ). 
Discussion
Diabetes mellitus is a worldwide epidemic and currently the most prevalent chronic illness in the world having a prevalence of around 9% in the adult population and 30% of Saudi adults. 9, 28 Moreover, VDD has received special attention lately because of its high incidence and its implication in the genesis of multiple chronic illnesses. VDD and T2DM are usually recognized as a complication and risk for thyroid disease. 29 We found VDD to be common (47.5%). In addition, high levels of TSH have been associated with lower 25-OHD levels. Moreover, suppressed levels of TSH have been associated with higher 25-OHD levels. In addition, a linear association between TSH and 25-OHD has been noticed among T2DM patients. Though higher levels of 25-OHD with suppressed TSH levels might be due to an increased absorption of 25-OHD in hyperthyroid state. Metabolism of 25-OHD is also reciprocally regulated by thyroid hormones. Histological examination of the skin in hypothyroid patients has shown epidermal thinning and hyperkeratosis. 30, 31 Finally, the body may not activate vitamin D properly.
32,33
We identified age, gender, HbA1c and TSH as the independent predictors of 25-OHD level. Thyroid disorders are more common in females by 5-10 times. 29, 34, 35 It has been shown that serum levels of 25-OHD decrease with age. 36 Moreover, we found age has shown a positive correlation with 25-OHD level. As the study population grow older, 25-OHD concentrations increase. We hypothesize that such finding due to the fact our subjects in the sixth decade of their lives (mean 50.5±13.7 years old). Higher levels of 25-OHD have been reported in older patients compared to younger counterparts. 37, 38 This could be due to the higher consumption of Vitamin D supplements in this age group. VDD has received special attention lately because of its high incidence and its implication in the genesis of multiple chronic illnesses. The high prevalence of VDD in our study population underlines the fact that VDD is more common in chronic diseases like diabetes mellitus. Our study showed that 25-OHD was inadequate in a half of our population of patients with T2DM. Lower 25-OHD levels were associated with a poor glycemic control. These findings are supported by a number of international studies. Some studies showed no association of a low 25-OHD levels with HbA1c levels. 39 But inverse correlation between the level of 25-OHD and HbA1c is well known. 40, 41 In many studies 25-OHD levels were low in subjects having higher HbA1c values in patients with T2DM indicating that they are inversely related. [42] [43] [44] We had some limitations. study was done at only one centre and was done at one point of time. The study sample confined to patients with T2DM but without comparable groups.
Conclusion
This study suggests positive associations between the VDD and TSH level among T2DM patients. Age, gender, HbA1c and TSH level were identified as the independent predictors of 25-OHD level.
